Ghent, Belgium

Richard Feichtinger

This inventor holds 2 USPTO granted patents. Top assignee: Devgen Nv. Active years: 2003-2006.


% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Richard Feichtinger: Innovator in Pharmacological Screening

Introduction

Richard Feichtinger is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of pharmacological research through his innovative methods of screening compounds using nematode worms. With a total of 2 patents, his work has the potential to advance drug discovery processes.

Latest Patents

Feichtinger's latest patents focus on methods of screening compounds for potential pharmacological activity using nematode worms. Specifically, these inventions relate to the use of modified nematodes that possess certain characteristics advantageous for compound screening. These characteristics include constitutive pharyngeal pumping, increased gut permeability, and altered gut molecular transport. Additionally, methods for selecting suitably modified nematodes from a population are also provided in his patents.

Career Highlights

Richard Feichtinger is associated with Devgen NV, a company that specializes in agricultural biotechnology. His work at Devgen has allowed him to explore innovative approaches to pharmacological screening, contributing to advancements in the field.

Collaborations

Feichtinger has collaborated with notable colleagues such as Philippe Verwaerde and Myriam Behgyn. These collaborations have likely enriched his research and contributed to the success of his inventions.

Conclusion

Richard Feichtinger's contributions to pharmacological screening through his innovative use of nematodes highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in drug discovery and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…